Form 4: Chicago Pacific Founders Increases Stake in P3 Health Partners Inc. (PIII) with Recent Stock Purchases
SEC Form 4 Filing
Chicago Pacific Founders UGP III, LLC, along with related entities, has increased its holdings in P3 Health Partners Inc. (PIII) through a series of open market purchases between September 4th and September 6th, 2024.
Summary
- Chicago Pacific Founders UGP III, LLC, and affiliated entities, have reported the acquisition of additional shares of P3 Health Partners Inc. (PIII) Class A Common Stock.
- The purchases occurred over three days, from September 4th to September 6th, 2024.
- A total of 240,000 shares were acquired across these three days, with 80,000 shares purchased on each day.
- The purchases were made at weighted average prices ranging from $0.4883 to $0.4912 per share.
- Following these transactions, the reporting entities' total indirect beneficial ownership of P3 Health Partners Inc. Class A Common Stock is 76,785,438 shares.
- The reporting entities include Chicago Pacific Founders UGP III, LLC, Chicago Pacific Founders GP III, L.P., CPF III PT SPV, LLC, and CPF III-A PT SPV, LLC.
- Chicago Pacific Founders UGP III, LLC is the general partner of Chicago Founders GP III, LP, which is the general partner of CPF III PT SPV, LLC and CPF III-A PT SPV, LLC.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The increased investment by a major shareholder suggests confidence, but the overall impact depends on the context of the company's performance and market conditions.
Positives
- The increased stake by Chicago Pacific Founders could be interpreted as a sign of confidence in P3 Health Partners' future prospects.
Industry Context
This activity is typical for investment firms that have a significant stake in a company, and may reflect their view on the company's valuation and potential for growth within the healthcare sector.
Comparison to Industry Standards
- Comparing this to other healthcare companies, similar purchases by major shareholders are often seen as a positive signal.
- For example, if a major shareholder in Oak Street Health (before its acquisition by CVS) had increased their stake, it would have been viewed similarly.
- However, the impact depends on the size of the purchase relative to the overall market capitalization and trading volume of P3 Health Partners.
Stakeholder Impact
- Shareholders may view the increased stake positively.
- Employees might see it as a sign of stability.
- Customers and suppliers may not be directly impacted by this transaction.
Key Dates
| Date | Description |
|---|---|
| 09/04/2024 | Purchase of 80,000 shares of Class A Common Stock at a weighted average price of $0.4883. |
| 09/05/2024 | Purchase of 80,000 shares of Class A Common Stock at a weighted average price of $0.4912. |
| 09/06/2024 | Purchase of 80,000 shares of Class A Common Stock at a weighted average price of $0.4898. |
| 09/10/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.